{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8ba317b4-7e33-4be6-a1fa-374c669c4f73",
   "metadata": {},
   "source": [
    "#### 환경"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6721a75b-d4d4-4a41-ae4e-0fab2cf86e5a",
   "metadata": {},
   "source": [
    "conda create -n qwen3 python=3.10   \n",
    "conda activate qwen3   \n",
    "pip install torch==2.6.0 torchvision==0.21.0 torchaudio==2.6.0 --index-url https://download.pytorch.org/whl/cu124    ## pytorch    \n",
    "pip install transformers accelerate bitsandbytes sentencepiece protobuf   ## LLM 모델    \n",
    "pip install huggingface_hub     # 허깅페이스 로그인    "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c1363df4-9188-4544-8f6d-1f6c06ced42c",
   "metadata": {},
   "source": [
    "#### 모델 선택"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f96d9194-c06d-4e2a-8158-d35d08a61d17",
   "metadata": {},
   "source": [
    "- 모델 파일크기로 필요 GPU메모리량 확인\n",
    "- 예) RTX 3090*2개 Qwen3-14B 모델 활용\n",
    "- huggingface 에 token 있으면 빠른 다운로드"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "6ad1699f-8f4d-479f-b5d5-386f8d849052",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/BiO/Live/jolee/anaconda3/envs/qwen-vl/lib/python3.10/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "GPUs available: 2\n",
      "  GPU 0: NVIDIA GeForce RTX 3090 - 23.6GB\n",
      "  GPU 1: NVIDIA GeForce RTX 3090 - 23.6GB\n",
      "Cleaning GPU memory...\n",
      "Step 1/2: Loading tokenizer...\n",
      "  Tokenizer loaded\n",
      "Step 2/2: Loading model (this takes 3-5 minutes)...\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "`torch_dtype` is deprecated! Use `dtype` instead!\n",
      "Loading checkpoint shards: 100%|██████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████████| 8/8 [00:09<00:00,  1.21s/it]\n"
     ]
    }
   ],
   "source": [
    "from transformers import AutoModelForCausalLM, AutoTokenizer\n",
    "import torch\n",
    "import gc\n",
    "import os\n",
    "\n",
    "model_name = \"Qwen/Qwen3-14B\"\n",
    "hf_token=\"hf_**********************\"\n",
    "\n",
    "# GPU 확인\n",
    "num_gpus = torch.cuda.device_count()\n",
    "print(f\"GPUs available: {num_gpus}\")\n",
    "for i in range(num_gpus):\n",
    "    props = torch.cuda.get_device_properties(i)\n",
    "    print(f\"  GPU {i}: {props.name} - {props.total_memory / 1024**3:.1f}GB\")\n",
    "\n",
    "# 메모리 정리\n",
    "print(\"Cleaning GPU memory...\")\n",
    "torch.cuda.empty_cache()\n",
    "gc.collect()\n",
    "\n",
    "# Tokenizer\n",
    "print(\"Step 1/2: Loading tokenizer...\")\n",
    "tokenizer = AutoTokenizer.from_pretrained(\n",
    "    model_name,\n",
    "    token=hf_token,\n",
    "    trust_remote_code=True\n",
    ")\n",
    "print(\"  Tokenizer loaded\")\n",
    "\n",
    "# Model\n",
    "print(\"Step 2/2: Loading model (this takes 3-5 minutes)...\")\n",
    "\n",
    "model = AutoModelForCausalLM.from_pretrained(\n",
    "    model_name,\n",
    "    token=hf_token,\n",
    "    torch_dtype=torch.float16,\n",
    "    device_map=\"auto\",\n",
    "    trust_remote_code=True,\n",
    "    low_cpu_mem_usage=True\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "9b7f64c9-eb74-4676-9218-a5df687d015f",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "def chat(model, message, max_tokens=2000, temperature=0.7):\n",
    "    messages = [\n",
    "        {\"role\": \"system\", \"content\": \"당신은 ACMG/AMP 변이 해석분야의 임상 유전학 전문가입니다.\"},\n",
    "        {\"role\": \"user\", \"content\": message}\n",
    "    ]\n",
    "    text = tokenizer.apply_chat_template(\n",
    "        messages,\n",
    "        tokenize=False,\n",
    "        add_generation_prompt=True\n",
    "    )\n",
    "\n",
    "    inputs = tokenizer([text], return_tensors=\"pt\").to(model.device)\n",
    "\n",
    "    print(\"Generating response...\")\n",
    "\n",
    "    with torch.no_grad():\n",
    "        # 메모리 정리\n",
    "        torch.cuda.empty_cache()\n",
    "\n",
    "        outputs = model.generate(\n",
    "            **inputs,\n",
    "            max_new_tokens=max_tokens,\n",
    "            temperature=temperature,\n",
    "            top_p=0.9,\n",
    "            do_sample=True,\n",
    "            pad_token_id=tokenizer.eos_token_id\n",
    "        )\n",
    "\n",
    "    num_tokens = len(outputs[0]) - len(inputs[0])\n",
    "\n",
    "    response = tokenizer.decode(\n",
    "        outputs[0][len(inputs[0]):],\n",
    "        skip_special_tokens=True\n",
    "    )\n",
    "\n",
    "    return response\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "1dd8df16-3e39-4d72-bfc0-b6d81444f817",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Generating response...\n"
     ]
    }
   ],
   "source": [
    "output = chat(model, message = \"\"\"ACMG/AMP 2015 가이드라인이란\"\"\",max_tokens=4000)\n",
    "print(output)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "a61b64d2-c4a7-4d59-ac3a-b5eb519cea80",
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "def analyze_variant(model, variant_info):\n",
    "        \"\"\"ACMG/AMP 2015 변이 분석 \"\"\"\n",
    "        prompt = f\"\"\"당신은 ACMG/AMP 2015 가이드라인과 ClinGen Sequence Variant Interpretation (SVI) 권고안에 따라 변이 해석을 수행하는 임상 유전학 전문가입니다.\n",
    "\n",
    "변이 정보:\n",
    "유전자: {variant_info.get('gene')}\n",
    "변이: {variant_info.get('variant')}\n",
    "유형: {variant_info.get('type')}\n",
    "cDNA: {variant_info.get('cdna', 'N/A')}\n",
    "단백질: {variant_info.get('protein', 'N/A')}\n",
    "\n",
    "증거 데이터:\n",
    "집단 데이터:\n",
    "- gnomAD AF (전체): {variant_info.get('gnomad_af', 'Unknown')}\n",
    "- gnomAD AF (popmax): {variant_info.get('gnomad_popmax', 'Unknown')}\n",
    "- gnomAD 동형접합: {variant_info.get('gnomad_hom', 'Unknown')}\n",
    "\n",
    "데이터베이스 증거:\n",
    "- ClinVar: {variant_info.get('clinvar', 'Not found')}\n",
    "- HGMD: {variant_info.get('hgmd', 'Not available')}\n",
    "\n",
    "전산 예측:\n",
    "- CADD: {variant_info.get('cadd', 'N/A')}\n",
    "- REVEL: {variant_info.get('revel', 'N/A')}\n",
    "- SpliceAI: {variant_info.get('spliceai', 'N/A')}\n",
    "- 보존성 (phyloP): {variant_info.get('phylop', 'N/A')}\n",
    "\n",
    "기능 연구:\n",
    "- In vitro 데이터: {variant_info.get('functional', 'N/A')}\n",
    "- In vivo 데이터: {variant_info.get('in_vivo', 'N/A')}\n",
    "\n",
    "가계 분리 및 증례 데이터:\n",
    "- 가계 분리: {variant_info.get('segregation', 'N/A')}\n",
    "- De novo: {variant_info.get('de_novo', 'N/A')}\n",
    "- 환자-대조군 연구: {variant_info.get('case_control', 'N/A')}\n",
    "\n",
    "과제: ACMG/AMP 2015 기준을 체계적으로 평가하세요. 각 기준(PVS1, PS1-4, PM1-6, PP1-5, BA1, BS1-4, BP1-7)에 대해 충족 여부를 증거와 근거와 함께 명시하세요. PS3/BS3와 PVS1 강도 조절에 대한 ClinGen SVI 권고안을 적용하세요. 최종 분류(병원성/병원성 가능/VUS/양성 가능/양성)를 신뢰도 및 임상적 해석과 함께 제공하세요.\"\"\"\n",
    "        \n",
    "        return chat(model, prompt, max_tokens=30000, temperature=0.2)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "1d427cd6-615b-4125-a690-dc7424138bb1",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Generating response...\n",
      "<think>\n",
      "Okay, let's tackle this variant interpretation for TP53 c.818G>A (p.Arg273His). First, I need to recall the ACMG/AMP 2015 guidelines and the ClinGen SVI recommendations. The user provided all the necessary data, so I should go through each criterion step by step.\n",
      "\n",
      "Starting with PVS1: This is for variants that cause a premature termination codon. But this is a missense variant, so PVS1 doesn't apply here. Next, PS1-4. PS1 is for a variant in a gene where all disease-causing variants are loss-of-function. TP53 is known for LOF variants causing Li-Fraumeni syndrome, but this is a missense. However, some missense variants in TP53 can be pathogenic. PS2 is for a variant in a critical and well-established functional domain. The Arg273 residue is in the DNA-binding domain of p53, which is crucial. So PS2 might apply. PS3 is for segregation data, but the user said it's not available. PS4 is for population data, but gnomAD AF is very low (0.000008), which is a strong PS4. \n",
      "\n",
      "PM1-6: PM1 is for a variant in a region of high conservation. The user didn't provide phyloP, so maybe not applicable. PM2 is for in silico prediction. CADD 28.5 and REVEL 0.95 are both high, so PM2 applies. PM3 is for functional studies. The in vitro data shows loss of transactivation, which is PM3. PM4 is for a variant in a gene where LOF variants are known to be pathogenic, but again, this is missense. PM5 is for a variant in a gene where LOF is a mechanism, but not sure. PM6 is for a variant in a gene with a known pathogenic variant in the same residue. The user didn't mention that, so maybe not.\n",
      "\n",
      "PP1-5: PP1 is for de novo, which isn't available. PP2 is for a variant in a gene where LOF is a mechanism, but again, this is missense. PP3 is for functional studies, which we have (PM3). PP4 is for a variant in a gene with a known pathogenic variant in the same residue. Not sure. PP5 is for a variant in a gene with a known pathogenic variant in the same residue. Not applicable here.\n",
      "\n",
      "BA1 is for a variant that is a known pathogenic variant in ClinVar. The user said ClinVar is Pathogenic, so BA1 applies. BS1-4: BS1 is for population frequency, but the AF is very low, so not applicable. BS2 is for a variant in a gene where LOF is a mechanism, but again, this is missense. BS3 is for a variant that is not observed in a large cohort of affected individuals, but the user didn't provide that. BS4 is for a variant that is not observed in a large cohort of unaffected individuals, but again, not provided.\n",
      "\n",
      "BP1-7: BP1 is for a variant in a gene where LOF is a mechanism, but this is missense. BP2 is for a variant in a gene where LOF is a mechanism, but again, not sure. BP3 is for a variant that is not observed in a large cohort of affected individuals. Not applicable. BP4 is for a variant that is not observed in a large cohort of unaffected individuals. Not applicable. BP5 is for a variant that is not observed in a large cohort of unaffected individuals. Not applicable. BP6 is for a variant that is not observed in a large cohort of unaffected individuals. Not applicable. BP7 is for a variant that is not observed in a large cohort of unaffected individuals. Not applicable.\n",
      "\n",
      "Now, considering ClinGen SVI for PS3/BS3 and PVS1. Since PVS1 doesn't apply, but PS4 is strong. The in vitro data (PM3) is strong. ClinVar is BA1. The CADD and REVEL are high (PM2). The population frequency is very low (PS4). So combining BA1, PS4, PM2, PM3, and PS2 (if applicable). \n",
      "\n",
      "Wait, PS2: the DNA-binding domain is a critical domain, so PS2 applies. So PS2 (strong), PS4 (strong), PM2 (moderate), PM3 (moderate), BA1 (strong). \n",
      "\n",
      "The criteria would be: BA1 (strong), PS2 (strong), PS4 (strong), PM2 (moderate), PM3 (moderate). \n",
      "\n",
      "According to ACMG, the classification would be Pathogenic. The user mentioned ClinVar is Pathogenic, which aligns with this. The low population frequency, strong in vitro evidence, and high prediction scores all support this. Even though it's a missense, the functional impact is significant. So the final classification is Pathogenic with high confidence.\n",
      "</think>\n",
      "\n",
      "### **TP53 c.818G>A (p.Arg273His) 변이 해석**  \n",
      "**유전자**: TP53  \n",
      "**변이 유형**: Missense (p.Arg273His)  \n",
      "**ACMG/AMP 2015 기준 및 ClinGen SVI 권고안에 따른 평가**  \n",
      "\n",
      "---\n",
      "\n",
      "### **1. ACMG/AMP 2015 기준 평가**  \n",
      "#### **PVS1 (Premature termination codon)**  \n",
      "- **적용 여부**: **불적용**  \n",
      "- **근거**: 이 변이는 **missense** 유형으로, 조기 종결 코돈을 유발하지 않음.  \n",
      "\n",
      "---\n",
      "\n",
      "#### **PS1-4 (Population and segregation data)**  \n",
      "- **PS1 (Population frequency)**:  \n",
      "  - **적용 여부**: **적용** (Strong)  \n",
      "  - **근거**: gnomAD 전체 인구에서의 빈도(AF)은 **0.000008** (1/125,000)으로, 매우 낮은 빈도.  \n",
      "  - **ClinGen SVI 권고안**: PS3/BS3 강도 조절 적용 시, **PS1은 강도가 유지됨**.  \n",
      "\n",
      "- **PS2 (Functional domain)**:  \n",
      "  - **적용 여부**: **적용** (Strong)  \n",
      "  - **근거**: Arg273은 **p53의 DNA-binding domain**에 위치하며, 이 영역은 p53의 기능에 핵심적인 역할을 함.  \n",
      "\n",
      "- **PS3 (Segregation data)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: 가계 분리 데이터가 제공되지 않음.  \n",
      "\n",
      "- **PS4 (Population frequency in affected individuals)**:  \n",
      "  - **적용 여부**: **적용** (Strong)  \n",
      "  - **근거**: gnomAD에서의 빈도가 매우 낮고, **TP53의 병리적 변이**는 일반적으로 높은 유전적 부담을 동반함.  \n",
      "\n",
      "---\n",
      "\n",
      "#### **PM1-6 (Functional and computational evidence)**  \n",
      "- **PM1 (Conservation)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: 보존성 데이터(phyloP)가 제공되지 않음.  \n",
      "\n",
      "- **PM2 (In silico prediction)**:  \n",
      "  - **적용 여부**: **적용** (Moderate)  \n",
      "  - **근거**:  \n",
      "    - **CADD**: 28.5 (높은 해해도, >20)  \n",
      "    - **REVEL**: 0.95 (높은 병리성 예측, >0.9)  \n",
      "    - **SpliceAI**: N/A (스플라이싱 영향 없음)  \n",
      "\n",
      "- **PM3 (Functional studies)**:  \n",
      "  - **적용 여부**: **적용** (Strong)  \n",
      "  - **근거**: **In vitro 실험**에서 **transactivation activity 손실**이 관찰됨.  \n",
      "\n",
      "- **PM4 (Known pathogenic variants in the same residue)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: 동일한 아미노산 위치의 병리적 변이가 제공되지 않음.  \n",
      "\n",
      "- **PM5 (Multiple lines of evidence)**:  \n",
      "  - **적용 여부**: **적용** (Moderate)  \n",
      "  - **근거**: **PM2 (in silico)** 및 **PM3 (functional)** 증거가 병리성에 일치함.  \n",
      "\n",
      "- **PM6 (De novo)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: de novo 데이터가 제공되지 않음.  \n",
      "\n",
      "---\n",
      "\n",
      "#### **PP1-5 (Partitioning of evidence)**  \n",
      "- **PP1 (De novo)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: de novo 데이터가 제공되지 않음.  \n",
      "\n",
      "- **PP2 (Gene-disease relationship)**:  \n",
      "  - **적용 여부**: **적용** (Moderate)  \n",
      "  - **근거**: TP53은 **Li-Fraumeni 증후군**과 관련된 **well-established disease gene**이며, missense 변이도 병리적일 수 있음.  \n",
      "\n",
      "- **PP3 (Functional studies)**:  \n",
      "  - **적용 여부**: **적용** (Moderate)  \n",
      "  - **근거**: **PM3 (functional studies)** 증거가 병리성에 일치함.  \n",
      "\n",
      "- **PP4 (Population frequency in unaffected individuals)**:  \n",
      "  - **적용 여부**: **적용** (Moderate)  \n",
      "  - **근거**: gnomAD에서의 빈도가 매우 낮음.  \n",
      "\n",
      "- **PP5 (Known pathogenic variants in the same residue)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: 동일한 아미노산 위치의 병리적 변이가 제공되지 않음.  \n",
      "\n",
      "---\n",
      "\n",
      "#### **BA1 (Known pathogenic variant in ClinVar)**  \n",
      "- **적용 여부**: **적용** (Strong)  \n",
      "- **근거**: **ClinVar에서 Pathogenic으로 분류됨**.  \n",
      "\n",
      "---\n",
      "\n",
      "#### **BS1-4 (Evidence against pathogenicity)**  \n",
      "- **BS1 (Population frequency)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: gnomAD 빈도가 매우 낮음.  \n",
      "\n",
      "- **BS2 (Functional studies)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: **PM3 (functional studies)** 증거가 병리성에 일치함.  \n",
      "\n",
      "- **BS3 (Population frequency in affected individuals)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: 환자-대조군 데이터가 제공되지 않음.  \n",
      "\n",
      "- **BS4 (Population frequency in unaffected individuals)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: gnomAD 빈도가 매우 낮음.  \n",
      "\n",
      "---\n",
      "\n",
      "#### **BP1-7 (Evidence against pathogenicity)**  \n",
      "- **BP1 (Gene-disease relationship)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: TP53은 **well-established disease gene**.  \n",
      "\n",
      "- **BP2 (Functional studies)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: **PM3 (functional studies)** 증거가 병리성에 일치함.  \n",
      "\n",
      "- **BP3 (Population frequency in affected individuals)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: 환자-대조군 데이터가 제공되지 않음.  \n",
      "\n",
      "- **BP4 (Population frequency in unaffected individuals)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: gnomAD 빈도가 매우 낮음.  \n",
      "\n",
      "- **BP5 (Known benign variants in the same residue)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: 동일한 아미노산 위치의 양성 변이가 제공되지 않음.  \n",
      "\n",
      "- **BP6 (Known benign variants in the same gene)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: TP53의 병리적 변이가 대부분 missense로 알려짐.  \n",
      "\n",
      "- **BP7 (Known benign variants in the same domain)**:  \n",
      "  - **적용 여부**: **불적용**  \n",
      "  - **근거**: DNA-binding domain의 병리적 변이가 잘 알려짐.  \n",
      "\n",
      "---\n",
      "\n",
      "### **2. 최종 분류 및 근거**  \n",
      "- **ACMG/AMP 기준**:  \n",
      "  - **Strong (BA1, PS2, PS4, PM3)**  \n",
      "  - **Moderate (PM2, PP2, PP3, PP4)**  \n",
      "  - **No evidence against pathogenicity**  \n",
      "\n",
      "- **ClinGen SVI 권고안**:  \n",
      "  - **PS3/BS3 강도 조절**: PS3 (segregation data)는 불적용, BS3 (population frequency in affected individuals)도 불적용.  \n",
      "  - **PVS1 강도 조절**: PVS1은 불적용.  \n",
      "\n",
      "- **최종 분류**: **병원성 (Pathogenic)**  \n",
      "- **신뢰도**: **고도 (High confidence)**  \n",
      "- **임상적 해석**:  \n",
      "  - TP53의 DNA-binding domain에 위치한 **p.Arg273His** 변이는 **in vitro 실험**에서 **transactivation activity 손실**을 유발하며, **ClinVar에서 병리성으로 분류됨**.  \n",
      "  - **gnomAD 빈도가 극히 낮고**, **CADD 및 REVEL 예측 점수가 높음**.  \n",
      "  - **TP53의 병리적 변이**는 대부분 missense 유형으로, 이 변이가 **Li-Fraumeni 증후군**과 관련될 가능성이 높음.  \n",
      "\n",
      "---\n",
      "\n",
      "### **3. 결론**  \n",
      "이 변이는 **ACMG/AMP 2015 기준** 및 **ClinGen SVI 권고안**에 따라 **병원성 (Pathogenic)**으로 분류됩니다. **고도의 신뢰도**를 기반으로, 임상적으로 **Li-Fraumeni 증후군**과 관련된 유전적 위험을 평가할 때 이 변이를 고려해야 합니다.\n"
     ]
    }
   ],
   "source": [
    "variant = {\n",
    "        'gene': 'TP53',\n",
    "        'variant': 'c.818G>A',\n",
    "        'type': 'missense',\n",
    "        'cdna': 'c.818G>A',\n",
    "        'protein': 'p.Arg273His',\n",
    "        'gnomad_af': '0.000008',\n",
    "        'clinvar': 'Pathogenic',\n",
    "        'cadd': '28.5',\n",
    "        'revel': '0.95',\n",
    "        'sift': 'deleterious',\n",
    "        'polyphen2_hvar': 'probably_damaging',\n",
    "        'protein_domain': 'DNA binding domain',\n",
    "        'is_hotspot': 'Yes',\n",
    "        'functional': 'Loss of transactivation activity',\n",
    "    }\n",
    "\n",
    "output= analyze_variant(model, variant)\n",
    "print(output)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5171beab-86b2-4a71-92ea-5749002f67c2",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "qwen3",
   "language": "python",
   "name": "qwen-vl"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
